Search

Filters

Clear Filters
5:20 PM - 5:25 PM ET

1094 - Risk Classifier for Treatment of Stage III Non-Small Cell Lung Cancer Using Competing Event Regression: Ancillary Analysis of RTOG 0617
Speaker: Morse, Ryan, MD - University of Kansas Medical Center, Kansas City, KS
5:25 PM - 5:30 PM ET

1095 - Predictors of Failure to Undergo Planned Resection after Neoadjuvant Chemoimmunotherapy for LA-NSCLC
Speaker: McDonald, Julian, BA - Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
5:30 PM - 5:35 PM ET

1096 - Peripheral PD-1?CD8? T-cell TCR Dynamics during Radiotherapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer
Speaker: Jiang, Ying, MD - Peking Union Medical College Hospital, Beijing, Beijing
5:05 PM - 5:10 PM ET

1097 - Comparison of Online Adaptive SBRT to Non-Adaptive SBRT in the Treatment of Abdominal and Pelvic Oligometastasis: A Single-Institution Retrospective Analysis
Speaker: Raclin, Tyler, MD - WashU Medicine, Saint Louis, MO
5:10 PM - 5:15 PM ET

1098 - Enhancing Workflow Efficiency in Simulation Free Radiation Therapy Using Diagnostic CT Realignment
Speaker: Lowe, Toby, RT - Royal North Shore Hospital, Sydney, NSW
5:15 PM - 5:20 PM ET

1099 - Implementing a Simulation-Free Workflow in Palliative Radiotherapy for Bone Metastases: Dosimetric Evaluation of Diagnostic CT-Based Planning Using 3D-CRT and VMAT
Speaker: Karaman, Emre, MD - Ege University Hospital, Izmir, N/A
2:10 PM - 2:20 PM ET

11 - Stereotactic Body Radiation Therapy (SBRT) and Comprehensive Metastasis-Directed Therapy for Ewing Sarcoma Patients Enrolled on AEWS1221: A Report from the Children's Oncology Group (COG)
Speaker: Laack, Nadia, MD, MS - Mayo Clinic, Rochester, MN
10:48 AM - 10:51 AM ET

11 - Stereotactic Body Radiation Therapy (SBRT) and Comprehensive Metastasis-Directed Therapy for Ewing Sarcoma Patients Enrolled on AEWS1221: A Report from the Children's Oncology Group (COG)
Speaker: Laack, Nadia, MD, MS - Mayo Clinic, Rochester, MN
3:00 PM - 3:10 PM ET

110 - Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer
Speaker: Lee, Nancy, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY
10:48 AM - 10:51 AM ET

110 - Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer
Speaker: Lee, Nancy, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY
5:20 PM - 5:25 PM ET

1100 - Cost Effectiveness of Prophylactic Bone Irradiation for Prevention of Skeletal-Related Events in Patients with Metastatic Solid Cancers
Speaker: Chacko, Sarah, BA - Geisel School of Medicine at Dartmouth, Lebanon, NH
5:25 PM - 5:30 PM ET

1101 - Concomitant Sub-ablative Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition in Recurrent and Metastatic Head and Neck Cancer
Speaker: Yazici, Gozde, MD - Hacettepe, Ankara, Ankara